Neuroscience
A fine read from the Pharmalot blog:
All Trial Data Must Be Disclosed: Rogawski Explains
By Ed Silverman
October 5th, 2011 - 9:36 am
Read the full blog posting
- Alzheimer's Disease: A Wrap For Bap
Trials for Alzheimer’s Drug Halted After Poor Results By KATIE THOMAS The New York Times 06 August 2012 Read full article ---Corporate Press Release: Read the releaseCommentary from the In The Pipeline blog: In The PipelineCommentary from Pharmalot:...
- Alzheimer's: Bapineuzumab And Solanezumab
Survey shows dim faith in Lilly, Pfizer Alzheimer's drugs Ransdell Pierson | Reuters The Chicago Tribune June 19, 2012 [snip] "Results from the survey of 146 investors were released late on Tuesday by Mark Schoenebaum, a pharmaceutical analyst for...
- Amyvid Approval
From Pharmalot blog, a good read about the Amyvid approval decision: Should FDA Have Approved Lilly Alzheimer’s Agent? Pharmalot By Ed Silverman April 9th, 2012 // 11:23 am Read the full blog post...
- From Pharmalot: Informed Consent Form Readibility
An interesting read. I always aimed for 6th-grade reading level myself, so it surprised me to read of this finding: Informed Consent Forms Target 11th Grade Readers By Ed Silverman Pharmalot December 12th, 2011 // 9:29 am Read the full blog post...
- American Academy Of Pediatrics New Adhd Clinical Practice Guideline
ADHD: Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents American Academy of Pediatrics pdf download Upon release, the new guideline resulted in a good deal...
Neuroscience
Pharmalot Interview with Dr. Michael Rogawski About Reporting Data in Clinical Trials
A fine read from the Pharmalot blog:
All Trial Data Must Be Disclosed: Rogawski Explains
By Ed Silverman
October 5th, 2011 - 9:36 am
Read the full blog posting
- Alzheimer's Disease: A Wrap For Bap
Trials for Alzheimer’s Drug Halted After Poor Results By KATIE THOMAS The New York Times 06 August 2012 Read full article ---Corporate Press Release: Read the releaseCommentary from the In The Pipeline blog: In The PipelineCommentary from Pharmalot:...
- Alzheimer's: Bapineuzumab And Solanezumab
Survey shows dim faith in Lilly, Pfizer Alzheimer's drugs Ransdell Pierson | Reuters The Chicago Tribune June 19, 2012 [snip] "Results from the survey of 146 investors were released late on Tuesday by Mark Schoenebaum, a pharmaceutical analyst for...
- Amyvid Approval
From Pharmalot blog, a good read about the Amyvid approval decision: Should FDA Have Approved Lilly Alzheimer’s Agent? Pharmalot By Ed Silverman April 9th, 2012 // 11:23 am Read the full blog post...
- From Pharmalot: Informed Consent Form Readibility
An interesting read. I always aimed for 6th-grade reading level myself, so it surprised me to read of this finding: Informed Consent Forms Target 11th Grade Readers By Ed Silverman Pharmalot December 12th, 2011 // 9:29 am Read the full blog post...
- American Academy Of Pediatrics New Adhd Clinical Practice Guideline
ADHD: Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents American Academy of Pediatrics pdf download Upon release, the new guideline resulted in a good deal...